EcoDrugPlus

Adam Metallopeptidase With Thrombospondin Type 1 Motif 5

Ensembl ID : ENSSTUG00000048566
Gene Symbol: ADAMTS5
3 Cross references
192 Possible Orthologues:

Adam Metallopeptidase With Thrombospondin Type 1 Motif 5

Ensembl ID : ENSSTUG00000005623
Gene Symbol: ADAMTS5
3 Cross references
193 Possible Orthologues:

Adrm1 26s Proteasome Ubiquitin Receptor

Ensembl ID : ENSSTUG00000010843
Gene Symbol: ADRM1
3 Cross references
185 Possible Orthologues:

Adrm1 26s Proteasome Ubiquitin Receptor

Ensembl ID : ENSSTUG00000011610
Gene Symbol: ADRM1
3 Cross references
184 Possible Orthologues:

Adrm1 26s Proteasome Ubiquitin Receptor

Ensembl ID : ENSSTUG00000006683
Gene Symbol: ADRM1
1 Cross references
12 Possible Orthologues:

Akt Serine/threonine Kinase 1

Ensembl ID : ENSSTUG00000047705
Gene Symbol: AKT1
3 Cross references
180 Possible Orthologues:

Akt Serine/threonine Kinase 1

Ensembl ID : ENSSTUG00000033404
Gene Symbol: AKT1
3 Cross references
144 Possible Orthologues:

Akt Serine/threonine Kinase 1

Ensembl ID : ENSSTUG00000003007
Gene Symbol: AKT1
3 Cross references
144 Possible Orthologues:

Akt Serine/threonine Kinase 1

Ensembl ID : ENSSTUG00000016663
Gene Symbol: AKT1
3 Cross references
181 Possible Orthologues:

Atp Binding Cassette Subfamily B Member 1

Ensembl ID : ENSSTUG00000033099
Gene Symbol: ABCB1
3 Cross references
164 Possible Orthologues:

Atp-Binding Cassette Sub-Family C Member 8-Like

Ensembl ID : ENSSTUG00000016339
Gene Symbol: LOC115197051
3 Cross references
223 Possible Orthologues:

Atp-Binding Cassette Sub-Family C Member 8-Like

Ensembl ID : ENSSTUG00000022504
Gene Symbol: LOC115192777
3 Cross references
223 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).